Put Patients, Not Politics, First at the FDA
|
Discussion Policy
Comments that include profanity or personal attacks or other inappropriate comments or material will be removed from the site. Additionally, entries that are unsigned or contain "signatures" by someone other than the actual author will be removed. Finally, we will take steps to block users who violate any of our posting standards, terms of use or privacy policies or any other policies governing this site. Please review the full rules governing commentaries and discussions. You are fully responsible for the content that you post.
|
The Aug. 3 editorial "Plan A: Approve Plan B" merely perpetuates the politicization of the Food and Drug Administration. The reality is that the FDA is being held hostage by both parties in the dispute over the emergency contraceptive. The use of the agency as a political pawn further sacrifices science and ultimately affects patients' access to potentially lifesaving therapies.
Andrew C. von Eschenbach, the nominee to head the FDA, made his commitment to science clear and reiterated that the balance between protecting and promoting public health is the principle that will guide all decisions at the FDA. He cannot lead the agency to its greatest effectiveness without permanent confirmation. It is true; the public deserves access to Plan B, but not at the greater expense of patient care. Please, recognize what is at risk without permanent leadership and make patients "Plan A."
ELLEN SIGAL
Chair
MARLENE MALEK
President
Friends of Cancer Research
Washington


